PONEZUMAB
UNII 1TG15H1XE9

Substance Identification & Data

This profile provides standardized clinical and technical data for Ponezumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 1TG15H1XE9.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1178862-65-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

1TG15H1XE9

CAS Registry Number

1178862-65-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PONEZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C97941

National Cancer Institute reference terminology for clinical and research data.

INN ID

9322

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

WW-143

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ponezumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PONEZUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G2, ANTI-(HUMAN .BETA.-AMYLOID) (HUMAN-MOUSE MONOCLONAL PF-04360365 CLONE 9TL HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL PF-04360365 CLONE 9TL LIGHT CHAIN, DIMER

PONEZUMAB [INN]

PONEZUMAB [USAN]

PONEZUMAB [WHO-DD]